欧洲在预测性、预防性和个体化医学方面的策略：2011 年 EPMA 世界大会的重点。

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011.

机构信息

European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium ; Department of Radiology, Friedrich-Wilhelms-University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.

出版信息

EPMA J. 2011 Dec;2(4):315-32. doi: 10.1007/s13167-011-0134-6. Epub 2011 Dec 29.

DOI:10.1007/s13167-011-0134-6

PMID:23199170

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3405403/

Abstract

This article highlights the central events of the EPMA World Congress 2011 - the strategic meeting of the European Association for Predictive, Preventive and Personalised Medicine (PPPM). European strategies related to PPPM have been discussed in specialised sessions dedicated toHealthcare in overview across the globeCollaboration with global organisationsGranting strategies in PPPMEducation in PPPMPatient needsTargeted preventionPPPM in reproductive medicine & paediatricsPPPM in diabetes carePPPM in neurodegenerative diseasesPPPM in cancerPPPM in cardiovascular diseasesInnovative PPPM-centresBiomarker validation and standardsPatient-specific modelling and bioinformatics in PPPMPPPM-related bio-preservation, biobanking & ethicsEPMA "expert recommendations" will be presented to Ministries of Health of 44 contributing countries, partner societies, associations, funding agencies and global organisations that participated in the congress. Full analysis of the outcomes will be provided during the next EPMA World Congress in September 2013.

摘要

本文重点介绍了 EPMA 世界大会 2011 年的重要事件——即欧洲预测、预防和个性化医学协会（PPPM）的战略会议。大会专门讨论了与 PPPM 相关的欧洲战略，涉及全球医疗保健概览、与全球组织的合作、PPPME 中的拨款策略、PPPME 中的教育、针对特定人群的预防、生殖医学和儿科中的 PPPM、糖尿病护理中的 PPPM、神经退行性疾病中的 PPPM、癌症中的 PPPM、心血管疾病中的 PPPM、创新的 PPPM 中心、生物标志物验证和标准、PPPME 中的患者特异性建模和生物信息学、与 PPPM 相关的生物保存、生物库和伦理学。EPMA 的“专家建议”将提交给 44 个有贡献的国家的卫生部、合作协会、协会、资助机构和参与大会的全球组织。在下一届 2013 年 9 月的 EPMA 世界大会上，将提供对这些结果的全面分析。